{
    "id": "32zu7mw4dosrqmcrxlinmcspiu4nj4rx",
    "title": "Clinical, pathological and molecular characterisation of C9orf72-ALS leads to identification of novel therapeutic targets",
    "info": {
        "author": [
            "Johnathan Cooper-Knock, Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield"
        ],
        "published": "Sept. 22, 2017",
        "recorded": "May 2017",
        "category": [
            "Top->Medicine",
            "Top->Medicine->Neuroscience"
        ]
    },
    "url": "http://videolectures.net/encals2017_cooper_knock_investigator_award/",
    "segmentation": [
        [
            "Yes, so first, let's just thank you again and the work I'm going to describe sort of mainly done during my PhD, is part of a group of people, etc.",
            "And get one.",
            "I'm going to talk about is sort of work that we've done describing clinical, pathological and molecular aspects of C9 or 72 LS.",
            "And you know how we've used that work to try and identify novel therapeutic target."
        ],
        [
            "So part of my talk first thing I'm going to talk about.",
            "You know, following on from the discovery of the C9 genetic variant, we sort of analyzed their own cohort and perform sort of clinical and pathological characterization.",
            "I then did quite a lot Southern blotting to size the C9 expansion, as did others.",
            "I'll talk a bit about that work and then you know, really utilizing our brain bank in Sheffield.",
            "We particularly focused on the RNA foci, particularly in within the motor neurons especially, and insights we gain from that and then at the end.",
            "Or sort of just talk a little bit about some gene expression profiling work, which I know genes can talk about more later."
        ],
        [
            "So.",
            "First of all, you know following on from the disease is 9 days in the Renton Papers end of 2011, the discovery of the C9 genetic variant.",
            "We sort of performed an initial sort of screening of our cohort in Sheffield, and we've identified a number of a less cases with the C9 genetic variant.",
            "47% of our familial cases and 7% of our sporadic cases.",
            "So you know, we identify in Sheffield every month and you see nine patient, which is, you know, an incredible opportunity.",
            "This is was a real game changer in the field.",
            "So important aspects of that characterization?",
            "I think you know the the fact that the C9 genetic variant clinically and pathologically resembles the more common sporadic disease you know that's given as real hope is a field that week, and things that we can learn from the C9 genetic variant therapies we can develop.",
            "We can then apply more broadly, and then you know, perhaps the most characteristic feature of C9 disease.",
            "The fact that there is this over representation of extra motor disease, and I'll talk a bit about that now."
        ],
        [
            "To see nine neuropathology, obviously there's the RNA foci, and then the DPR pathology that is being talked about extensively, particularly pathologies being expensive.",
            "We talked about last couple of days, there's the fact that you know within C9 we get these TDP 43 positive cytoplasmic inclusions.",
            "These are sort of neurons within the cortex, but obviously they occur within new in motor neurons, and that's that.",
            "You know that, perhaps the hallmark pathology of glass.",
            "And we see in the C9 genetic variant you know which is which.",
            "I think is really encouraging.",
            "Another I'll come back to that.",
            "But also you know in our paper we showed that there is these P 62 positive TDP 40, three negative inclusions within extra motor areas.",
            "Particularly this is from hippocampus and you know we another showed that they are, you know in a blinded manner we could identify RC9 cases just by looking for this pathology and you know it's been shown that this pathology includes.",
            "Some of the DPR proteins as well.",
            "You know an interesting insight and we still got more to learn about that.",
            "Hope.",
            "What?"
        ],
        [
            "There we go.",
            "So within our initial screening, we notice that about 8% of our patients had a diagnosis of Parkinson's disease or a family history of Parkinson's disease.",
            "So we set out to determine whether C9 expansions were A cause of park idiopathic Parkinson's disease.",
            "We screened 518 patients, and where I think our cohort of Parkinson's patients was different from some of the other papers came out at the same time, is that we had.",
            "This was pathologically proven Alpha Synuclein positive.",
            "Louis Buzzy idiopathic Parkinson's disease you know is pathologically diagnosed as as well as clinically.",
            "And of those 518 patients, only one carried a C9 expansion, so the frequency was similar to in our control population.",
            "And actually, when you looked at that patient, they weren't typical.",
            "They they actually had a family history of a lesson.",
            "They had pathology consistent with C9 ALS.",
            "So our conclusion was that you know, no, C9 expansions are not a significant cause of Lewy body positive, idiopathic, Parkinson's disease.",
            "When we did it from the other direction, we screened aralast cases.",
            "How many of them had Parkinson's disease or pathologically proven Parkinson's disease, and only two did and only one of those had the C9 expansion, so again, suggesting that it's not a common cause of classical idiopathic Parkinson's disease.",
            "So what then explains the parkinsonism?",
            "You know, you do see it in the scene I impatience, and it's certainly overrepresented.",
            "We looked in the the substantial nigra var.",
            "C9 LS patients.",
            "And we found that there was new generation and there was this.",
            "This pathology I've already shown you this.",
            "P62 positive pathology accompanying neurodegeneration and that was distinctly different from our non C9 LS cases.",
            "So you know what we're seeing here is this widespread new generation that's affecting the substantial Niagara and possibly explaining the parkinsonism."
        ],
        [
            "Multiple sclerosis so 5% of our patients had a diagnosis or a family history of demyelination and so we took a similar approach.",
            "We screened 215 cases with multiple sclerosis and particularly over representing cases with family history of multiple sclerosis to see if any of them have the C9 expansion and no, they didn't.",
            "There was none of those 215 cases carried a C9 expansion suggesting that scene is not a significant cause of multiple sclerosis.",
            "However, we also we prospectively identified in our Sheffield Cohort 7 cases with multiple sclerosis, who subsequently developed a LS and of those seven cases 80% had a C9 expansion, which is more than would be expected by chance.",
            "There's some starts there.",
            "So what explains this?",
            "I think we gained a lot of insight from looking at this pedigree here.",
            "So the index case indicated by an arrow was a lady hard Ms. She had a less and she had a C9 expansion.",
            "We had a family history of a less.",
            "Her daughter developed multiple sclerosis but didn't have a C9 expansion, so a daughter is inherited.",
            "Effectively, the multiple sclerosis without the C9 expansion, suggesting that the C9 expansion is is not a cause of her her multiple sclerosis, despite the fact that she has them all together.",
            "The way we've sort of explained this is, we think what's happening is that the multiple sclerosis is increasing the penetrance of the C9 expansion.",
            "So if you have a scene on expansion and then you have multiple sclerosis, then it's more likely to become penetrant.",
            "And sort of consistent with that.",
            "We found that senile asses more rapidly progressive in the presence of multiple sclerosis."
        ],
        [
            "Instead of building on this, we looked at him some sort of inflammatory cytokines, and this is a sort of measured at protein level in CSF.",
            "SXL tennis is normally elevated in multiple sclerosis and it has been shown to be sort of neuroprotective, potentially neuroprotective in LS LS cases with a higher level of CX.",
            "CL 1010 tend to have a more benign disease course and but you can see that the C9 ALS cases have a lower level compared to both control Xanten on C9 or less cases.",
            "So suggesting that potentially is a failure of this response in C9 particularly, that might be a potential therapeutic target."
        ],
        [
            "So moving on to Southern blotting, I did a lot of southern blotting.",
            "In collaboration with flooding near Buckman in Cardiff and utilizing the Mnda Lymphoblastoid cell bank and we perform sort of using them for blastoid cells, but also DNA extracted from other tissues and we like others, showed that there was significant somatic achaogen arity.",
            "So our protocol for Southern Blotting and our probe gives her a bandit 1.3 kilobases, which is the normal length allele, and then the expanded early on the shown above and you can see that this is from a single case and there is this significant heterogeneity between areas that 1.05 killer baseband is is a control band."
        ],
        [
            "So we said we have a very interesting case.",
            "You identified in Sheffield are a lady who has pure FTD or had pure FTD and she had two C9 expansions, so she had a she you can see that she has no normal length expansion.",
            "She has one expansion of about 50 repeat and then one of well over 2000 repeats.",
            "Compared to these cases which have a single, they have a normal length, illegal and then an expanded earlier and.",
            "And we use this to explore transcription of C9 or 72 M RNA, so I know it's a little bit controversial, but in our hands we do find a reduction in levels of C9 or 72 M RNA in in the expansion carriers and we look to see if there is a you know what was the effective expansion length on this transcription and when you look in the case with two expansions, the level of scenario 72 M RNA is approximately similar to those cases.",
            "You only have 1 expansion and the way we've interpreted that is suggesting that you know this this this expansion of only 50 repeats is not having an effect on transcription of that allele, and then that's been borne out by.",
            "Others have shown that there's a length dependent effect on epigenetic modification and potentially really explaining this finding and suggesting that the repeat length it has to be sort of much longer than 50 repeats to reduce that transcription."
        ],
        [
            "So moving onto RNA foci work and an immediate chemistry.",
            "So obviously the C9 expansion it's been talked about it's transcribed both sense and antisense, and both the sensor on the antisense transcripts conforming to these large RNA foci which are visible by fish.",
            "You know, we've published looking at both sort of the sense and the antisense transcripts and characterizing them."
        ],
        [
            "So summarizing some of our findings.",
            "They you know, working on the hypothesis that the you know similar to in my atonic dystrophy might see that the foci bind to proteins, sequester them in and prevent them doing their normal function, and that might be a mechanism of toxicity.",
            "We looked at binding partners of the sense and antisense transcripts, and we showed actually that the sender sends transcripts have broadly similar binding partners so.",
            "We like others and showed that those binding partners are predominantly RNA binding proteins involved in RNA splicing and actually some of that many of the binding partners are similar.",
            "So this just shows for Allie Ref that there is colocalization with the foci for boat in boat with both the antisense in the sense and then we did some UV crosslinking studies and showed again that those are the UV crosslinking allows us to look at direct interactions with the transcripts and showed that all of these.",
            "RNA binding proteins interact with both the sense and antisense transcripts.",
            "So if sequestration of these RNA binding proteins is key to toxicity, both the sense in the antisense have similar binding partners."
        ],
        [
            "Where they're very different is is in their levels of transcription, in different neuronal populations.",
            "So what we showed is that motor neurons and I just say all this work was done blinded, but motor neurons have a higher frequency of antisense foci compared to sense, as do Purkinje neurons, whereas the granule neurons in the cerebellum have a higher level of sense compared to anti sense foci.",
            "So there appears to be a different neuronal populations have a different propensity to transcribe the sensor.",
            "$0.50"
        ],
        [
            "Conscripts.",
            "When in different cases have different levels of foci, so for instance case one here has much higher levels of both sense and antisense foci compared to these other cases.",
            "But the ratios are approximately similar between between this antisense in the sense in each case, so they have similar ratios of anti sense to sense, but the absolute levels can vary between cases.",
            "What's interesting about this is that case one is a patient who developed FTD initially, so extra motor disease and then went on to develop a less, whereas these other cases.",
            "Are pure air less cases and case one has a higher level of foci?",
            "High frequency of foci in extra motor areas compared to motor neurons.",
            "As you can see here, where is the other cases of the opposite?",
            "This is a single case.",
            "You can't base conclusions on a single case, but the fact that the foci distribution is is is correlating with the clinical phenotype is is interesting and needs further work."
        ],
        [
            "So the other comparison we did, we looked in whether the foci within motor neurons could predict the presence of TDP pathology.",
            "You know, I've already said that TDP pathologies you know the Hallmark Pathology Avaya last.",
            "It's the one pathology that predicts neurodegeneration.",
            "So when we looked at the sense fosite, we showed that there was no correlation within motor neurons, so the presence of a sense foci within a motor neuron does not predict the presence of TDP, pathology or TP mislocalization.",
            "And I must admit I came to the antisense expecting to find the same and found the opposite.",
            "So the presence of an antisense foci within a motor neuron strongly predicts the presence of TDP 43 pathology.",
            "We came up.",
            "This result was very interesting, it suggesting a role for the antisense foci, particularly in in your generation, and the review is asked us to go and do more.",
            "We did more the P value just went down and down.",
            "You know, I think this is a robust finding."
        ],
        [
            "So conclude the RNA foci work.",
            "So the presence of the antisense foci correlates with TDP 43 mislocalization within the motor neurons.",
            "Now this ends in the antisense foci have similar binding partners, so if that if sequestration of binding proteins is the mechanism of toxicity, they should be equally toxic.",
            "However, what is different is that different neuronal populations appear to transcribe one or the other preferentially."
        ],
        [
            "And it says it's a more recent papers, sort of.",
            "I've also highlighted the antisense transcripts, you know, so I think supporting our work and draw particular attention to Laura Adams mouse model Gnosis is seen.",
            "I'm back mouse model.",
            "That is, is you know it is it has a robust phenotype.",
            "It has TDP 43 pathology unlike some of the other C9 back models that they have been sort of published and where I think it really differs from the other mouse models is that it has a higher level of antisense transcription.",
            "And what's really interesting is that the antisense transcription appears to be highest in the neuronal populations where there is degeneration, whereas this sense transcription and appears to be sort of more uniform across neuronal populations.",
            "So you know, like our work, sort of highlighting that antisense transcription."
        ],
        [
            "So quick summary of some gene expression profiling work, so we based on this, you know.",
            "So there are multiple lines of evidence that have highlighted M RNA splicing in C9.",
            "So this worker already talked about sort of the foci.",
            "Perhaps sequestering RNA binding proteins?",
            "But also, you know, we've the dipeptide repeat proteins thought to disrupt the normal sort of maturation of the splicing proteins.",
            "So whichever way you come to it, and perhaps both ways at once.",
            "There's you know you expect a disruption of RNA splicing, and so we tried to sort of measure that.",
            "So what we did?",
            "We did some gene expression profiling and we tried to measure splicing errors.",
            "And how do you define a splicing error?",
            "So the way we did this is we said that if you take a group of samples, splicing events that are common to all samples are more likely to be not errors.",
            "But if they if they only occur in one sample, they might not be an error, but they're more likely to be an error.",
            "So in this way we sort of measured splicing errors, and we showed that.",
            "Measured in this way, splicing errors are higher in RC9 cases compared to non C9 and to controls, and perhaps most Interestingly cases with a C9 cases with more of these errors have a faster progression than those with less of these errors, and suggesting there's a correlation with clinical phenotype.",
            "I think that needs further work."
        ],
        [
            "So where do we go from here?",
            "So I think you know, I thought about seeing what what might really sort of excited about.",
            "I think the the forthcoming antisense oligo trial in C9.",
            "I'm excited about, you know if whether it's the first side of the DPR, if it's gain of function toxicity, I think you know we, that's that's a really exciting trial coming up.",
            "I think you know I've already highlighted the understands transcription in the role of that, and I think you know we're already seeing good models that sort of highlighting that, and I think the measuring the length of the expansion are Russell talk.",
            "Yesterday was fantastic and I thought, you know, I think looking to measure the expansion using a nanopore based technology.",
            "Whether that's Pat BioWare, that's the Oxford nanopore.",
            "I think that's going to be really important.",
            "It's kind of the missing piece, you know.",
            "We've had some hints through studies of anticipation that the repeat length is definitely key.",
            "But until we can accurately measure the repeat length, we don't know for definite that the repeat length is key and a lot of our our work at the moment is sort of working on that assumption.",
            "I think it I think it is likely to be, you know, gain of function toxicity that repeat length does determine phenotype, but until we can accurately measure that, it's kind of the missing piece and the other thing I want to highlight, you know, I thought.",
            "Again, Russell mentioned this the fascinating insight into the genetic architecture of a LS from the project mine work, you know, done so far that.",
            "We're looking at combinations of rare variants.",
            "I think that's fascinating.",
            "I think, as you know, we probably going to discover many, many more genes.",
            "You know, this whole we've discovered the genes in 80% of familiars samples.",
            "I think.",
            "Really, you know, if multiple if patients have several mutations that are all that are rare, acting in combination is going to be so much work to do in dissecting the interactions.",
            "You know, perhaps seeing synergy synergy between different mutations, and hopefully that's going to highlight lots of therapeutic targets.",
            "So."
        ],
        [
            "An I've got so many people to say thank you for for for all of this this work you know it's a lot of a lot of work I've described here.",
            "I can't mention everybody, I just want to highlight these people so Adrian game, win, pull Robin and my supervisors during my PhD, Janine and Pam.",
            "This is the US getting wet that spam getting wet outside to trend where we work."
        ],
        [
            "And then just want to highlight collaborators, Vlad, Magnus, John Bryan China Deaton, Michael, born from San Diego and and again I want to highlight the Lymphoblastoid cell bank.",
            "The MDF used that in a lot of the work I've described to you.",
            "People who funded me through my PhD, the MDA, the MRC and people from me.",
            "Now the NHL and thank you for listening."
        ]
    ],
    "summarization": {
        "clip_0": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Yes, so first, let's just thank you again and the work I'm going to describe sort of mainly done during my PhD, is part of a group of people, etc.",
                    "label": 0
                },
                {
                    "sent": "And get one.",
                    "label": 0
                },
                {
                    "sent": "I'm going to talk about is sort of work that we've done describing clinical, pathological and molecular aspects of C9 or 72 LS.",
                    "label": 1
                },
                {
                    "sent": "And you know how we've used that work to try and identify novel therapeutic target.",
                    "label": 0
                }
            ]
        },
        "clip_1": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "So part of my talk first thing I'm going to talk about.",
                    "label": 0
                },
                {
                    "sent": "You know, following on from the discovery of the C9 genetic variant, we sort of analyzed their own cohort and perform sort of clinical and pathological characterization.",
                    "label": 0
                },
                {
                    "sent": "I then did quite a lot Southern blotting to size the C9 expansion, as did others.",
                    "label": 1
                },
                {
                    "sent": "I'll talk a bit about that work and then you know, really utilizing our brain bank in Sheffield.",
                    "label": 0
                },
                {
                    "sent": "We particularly focused on the RNA foci, particularly in within the motor neurons especially, and insights we gain from that and then at the end.",
                    "label": 0
                },
                {
                    "sent": "Or sort of just talk a little bit about some gene expression profiling work, which I know genes can talk about more later.",
                    "label": 0
                }
            ]
        },
        "clip_2": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "So.",
                    "label": 0
                },
                {
                    "sent": "First of all, you know following on from the disease is 9 days in the Renton Papers end of 2011, the discovery of the C9 genetic variant.",
                    "label": 0
                },
                {
                    "sent": "We sort of performed an initial sort of screening of our cohort in Sheffield, and we've identified a number of a less cases with the C9 genetic variant.",
                    "label": 0
                },
                {
                    "sent": "47% of our familial cases and 7% of our sporadic cases.",
                    "label": 1
                },
                {
                    "sent": "So you know, we identify in Sheffield every month and you see nine patient, which is, you know, an incredible opportunity.",
                    "label": 0
                },
                {
                    "sent": "This is was a real game changer in the field.",
                    "label": 0
                },
                {
                    "sent": "So important aspects of that characterization?",
                    "label": 1
                },
                {
                    "sent": "I think you know the the fact that the C9 genetic variant clinically and pathologically resembles the more common sporadic disease you know that's given as real hope is a field that week, and things that we can learn from the C9 genetic variant therapies we can develop.",
                    "label": 0
                },
                {
                    "sent": "We can then apply more broadly, and then you know, perhaps the most characteristic feature of C9 disease.",
                    "label": 0
                },
                {
                    "sent": "The fact that there is this over representation of extra motor disease, and I'll talk a bit about that now.",
                    "label": 0
                }
            ]
        },
        "clip_3": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "To see nine neuropathology, obviously there's the RNA foci, and then the DPR pathology that is being talked about extensively, particularly pathologies being expensive.",
                    "label": 0
                },
                {
                    "sent": "We talked about last couple of days, there's the fact that you know within C9 we get these TDP 43 positive cytoplasmic inclusions.",
                    "label": 0
                },
                {
                    "sent": "These are sort of neurons within the cortex, but obviously they occur within new in motor neurons, and that's that.",
                    "label": 0
                },
                {
                    "sent": "You know that, perhaps the hallmark pathology of glass.",
                    "label": 0
                },
                {
                    "sent": "And we see in the C9 genetic variant you know which is which.",
                    "label": 0
                },
                {
                    "sent": "I think is really encouraging.",
                    "label": 0
                },
                {
                    "sent": "Another I'll come back to that.",
                    "label": 0
                },
                {
                    "sent": "But also you know in our paper we showed that there is these P 62 positive TDP 40, three negative inclusions within extra motor areas.",
                    "label": 0
                },
                {
                    "sent": "Particularly this is from hippocampus and you know we another showed that they are, you know in a blinded manner we could identify RC9 cases just by looking for this pathology and you know it's been shown that this pathology includes.",
                    "label": 0
                },
                {
                    "sent": "Some of the DPR proteins as well.",
                    "label": 0
                },
                {
                    "sent": "You know an interesting insight and we still got more to learn about that.",
                    "label": 0
                },
                {
                    "sent": "Hope.",
                    "label": 0
                },
                {
                    "sent": "What?",
                    "label": 0
                }
            ]
        },
        "clip_4": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "There we go.",
                    "label": 0
                },
                {
                    "sent": "So within our initial screening, we notice that about 8% of our patients had a diagnosis of Parkinson's disease or a family history of Parkinson's disease.",
                    "label": 1
                },
                {
                    "sent": "So we set out to determine whether C9 expansions were A cause of park idiopathic Parkinson's disease.",
                    "label": 0
                },
                {
                    "sent": "We screened 518 patients, and where I think our cohort of Parkinson's patients was different from some of the other papers came out at the same time, is that we had.",
                    "label": 0
                },
                {
                    "sent": "This was pathologically proven Alpha Synuclein positive.",
                    "label": 0
                },
                {
                    "sent": "Louis Buzzy idiopathic Parkinson's disease you know is pathologically diagnosed as as well as clinically.",
                    "label": 1
                },
                {
                    "sent": "And of those 518 patients, only one carried a C9 expansion, so the frequency was similar to in our control population.",
                    "label": 0
                },
                {
                    "sent": "And actually, when you looked at that patient, they weren't typical.",
                    "label": 1
                },
                {
                    "sent": "They they actually had a family history of a lesson.",
                    "label": 1
                },
                {
                    "sent": "They had pathology consistent with C9 ALS.",
                    "label": 0
                },
                {
                    "sent": "So our conclusion was that you know, no, C9 expansions are not a significant cause of Lewy body positive, idiopathic, Parkinson's disease.",
                    "label": 0
                },
                {
                    "sent": "When we did it from the other direction, we screened aralast cases.",
                    "label": 0
                },
                {
                    "sent": "How many of them had Parkinson's disease or pathologically proven Parkinson's disease, and only two did and only one of those had the C9 expansion, so again, suggesting that it's not a common cause of classical idiopathic Parkinson's disease.",
                    "label": 0
                },
                {
                    "sent": "So what then explains the parkinsonism?",
                    "label": 0
                },
                {
                    "sent": "You know, you do see it in the scene I impatience, and it's certainly overrepresented.",
                    "label": 0
                },
                {
                    "sent": "We looked in the the substantial nigra var.",
                    "label": 0
                },
                {
                    "sent": "C9 LS patients.",
                    "label": 0
                },
                {
                    "sent": "And we found that there was new generation and there was this.",
                    "label": 0
                },
                {
                    "sent": "This pathology I've already shown you this.",
                    "label": 0
                },
                {
                    "sent": "P62 positive pathology accompanying neurodegeneration and that was distinctly different from our non C9 LS cases.",
                    "label": 0
                },
                {
                    "sent": "So you know what we're seeing here is this widespread new generation that's affecting the substantial Niagara and possibly explaining the parkinsonism.",
                    "label": 0
                }
            ]
        },
        "clip_5": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Multiple sclerosis so 5% of our patients had a diagnosis or a family history of demyelination and so we took a similar approach.",
                    "label": 1
                },
                {
                    "sent": "We screened 215 cases with multiple sclerosis and particularly over representing cases with family history of multiple sclerosis to see if any of them have the C9 expansion and no, they didn't.",
                    "label": 0
                },
                {
                    "sent": "There was none of those 215 cases carried a C9 expansion suggesting that scene is not a significant cause of multiple sclerosis.",
                    "label": 0
                },
                {
                    "sent": "However, we also we prospectively identified in our Sheffield Cohort 7 cases with multiple sclerosis, who subsequently developed a LS and of those seven cases 80% had a C9 expansion, which is more than would be expected by chance.",
                    "label": 0
                },
                {
                    "sent": "There's some starts there.",
                    "label": 0
                },
                {
                    "sent": "So what explains this?",
                    "label": 0
                },
                {
                    "sent": "I think we gained a lot of insight from looking at this pedigree here.",
                    "label": 0
                },
                {
                    "sent": "So the index case indicated by an arrow was a lady hard Ms. She had a less and she had a C9 expansion.",
                    "label": 0
                },
                {
                    "sent": "We had a family history of a less.",
                    "label": 0
                },
                {
                    "sent": "Her daughter developed multiple sclerosis but didn't have a C9 expansion, so a daughter is inherited.",
                    "label": 0
                },
                {
                    "sent": "Effectively, the multiple sclerosis without the C9 expansion, suggesting that the C9 expansion is is not a cause of her her multiple sclerosis, despite the fact that she has them all together.",
                    "label": 0
                },
                {
                    "sent": "The way we've sort of explained this is, we think what's happening is that the multiple sclerosis is increasing the penetrance of the C9 expansion.",
                    "label": 0
                },
                {
                    "sent": "So if you have a scene on expansion and then you have multiple sclerosis, then it's more likely to become penetrant.",
                    "label": 0
                },
                {
                    "sent": "And sort of consistent with that.",
                    "label": 1
                },
                {
                    "sent": "We found that senile asses more rapidly progressive in the presence of multiple sclerosis.",
                    "label": 0
                }
            ]
        },
        "clip_6": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Instead of building on this, we looked at him some sort of inflammatory cytokines, and this is a sort of measured at protein level in CSF.",
                    "label": 0
                },
                {
                    "sent": "SXL tennis is normally elevated in multiple sclerosis and it has been shown to be sort of neuroprotective, potentially neuroprotective in LS LS cases with a higher level of CX.",
                    "label": 1
                },
                {
                    "sent": "CL 1010 tend to have a more benign disease course and but you can see that the C9 ALS cases have a lower level compared to both control Xanten on C9 or less cases.",
                    "label": 1
                },
                {
                    "sent": "So suggesting that potentially is a failure of this response in C9 particularly, that might be a potential therapeutic target.",
                    "label": 0
                }
            ]
        },
        "clip_7": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "So moving on to Southern blotting, I did a lot of southern blotting.",
                    "label": 1
                },
                {
                    "sent": "In collaboration with flooding near Buckman in Cardiff and utilizing the Mnda Lymphoblastoid cell bank and we perform sort of using them for blastoid cells, but also DNA extracted from other tissues and we like others, showed that there was significant somatic achaogen arity.",
                    "label": 0
                },
                {
                    "sent": "So our protocol for Southern Blotting and our probe gives her a bandit 1.3 kilobases, which is the normal length allele, and then the expanded early on the shown above and you can see that this is from a single case and there is this significant heterogeneity between areas that 1.05 killer baseband is is a control band.",
                    "label": 0
                }
            ]
        },
        "clip_8": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So we said we have a very interesting case.",
                    "label": 0
                },
                {
                    "sent": "You identified in Sheffield are a lady who has pure FTD or had pure FTD and she had two C9 expansions, so she had a she you can see that she has no normal length expansion.",
                    "label": 0
                },
                {
                    "sent": "She has one expansion of about 50 repeat and then one of well over 2000 repeats.",
                    "label": 0
                },
                {
                    "sent": "Compared to these cases which have a single, they have a normal length, illegal and then an expanded earlier and.",
                    "label": 0
                },
                {
                    "sent": "And we use this to explore transcription of C9 or 72 M RNA, so I know it's a little bit controversial, but in our hands we do find a reduction in levels of C9 or 72 M RNA in in the expansion carriers and we look to see if there is a you know what was the effective expansion length on this transcription and when you look in the case with two expansions, the level of scenario 72 M RNA is approximately similar to those cases.",
                    "label": 0
                },
                {
                    "sent": "You only have 1 expansion and the way we've interpreted that is suggesting that you know this this this expansion of only 50 repeats is not having an effect on transcription of that allele, and then that's been borne out by.",
                    "label": 0
                },
                {
                    "sent": "Others have shown that there's a length dependent effect on epigenetic modification and potentially really explaining this finding and suggesting that the repeat length it has to be sort of much longer than 50 repeats to reduce that transcription.",
                    "label": 0
                }
            ]
        },
        "clip_9": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "So moving onto RNA foci work and an immediate chemistry.",
                    "label": 0
                },
                {
                    "sent": "So obviously the C9 expansion it's been talked about it's transcribed both sense and antisense, and both the sensor on the antisense transcripts conforming to these large RNA foci which are visible by fish.",
                    "label": 0
                },
                {
                    "sent": "You know, we've published looking at both sort of the sense and the antisense transcripts and characterizing them.",
                    "label": 1
                }
            ]
        },
        "clip_10": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So summarizing some of our findings.",
                    "label": 0
                },
                {
                    "sent": "They you know, working on the hypothesis that the you know similar to in my atonic dystrophy might see that the foci bind to proteins, sequester them in and prevent them doing their normal function, and that might be a mechanism of toxicity.",
                    "label": 0
                },
                {
                    "sent": "We looked at binding partners of the sense and antisense transcripts, and we showed actually that the sender sends transcripts have broadly similar binding partners so.",
                    "label": 0
                },
                {
                    "sent": "We like others and showed that those binding partners are predominantly RNA binding proteins involved in RNA splicing and actually some of that many of the binding partners are similar.",
                    "label": 0
                },
                {
                    "sent": "So this just shows for Allie Ref that there is colocalization with the foci for boat in boat with both the antisense in the sense and then we did some UV crosslinking studies and showed again that those are the UV crosslinking allows us to look at direct interactions with the transcripts and showed that all of these.",
                    "label": 0
                },
                {
                    "sent": "RNA binding proteins interact with both the sense and antisense transcripts.",
                    "label": 0
                },
                {
                    "sent": "So if sequestration of these RNA binding proteins is key to toxicity, both the sense in the antisense have similar binding partners.",
                    "label": 0
                }
            ]
        },
        "clip_11": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Where they're very different is is in their levels of transcription, in different neuronal populations.",
                    "label": 0
                },
                {
                    "sent": "So what we showed is that motor neurons and I just say all this work was done blinded, but motor neurons have a higher frequency of antisense foci compared to sense, as do Purkinje neurons, whereas the granule neurons in the cerebellum have a higher level of sense compared to anti sense foci.",
                    "label": 0
                },
                {
                    "sent": "So there appears to be a different neuronal populations have a different propensity to transcribe the sensor.",
                    "label": 0
                },
                {
                    "sent": "$0.50",
                    "label": 0
                }
            ]
        },
        "clip_12": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Conscripts.",
                    "label": 0
                },
                {
                    "sent": "When in different cases have different levels of foci, so for instance case one here has much higher levels of both sense and antisense foci compared to these other cases.",
                    "label": 1
                },
                {
                    "sent": "But the ratios are approximately similar between between this antisense in the sense in each case, so they have similar ratios of anti sense to sense, but the absolute levels can vary between cases.",
                    "label": 0
                },
                {
                    "sent": "What's interesting about this is that case one is a patient who developed FTD initially, so extra motor disease and then went on to develop a less, whereas these other cases.",
                    "label": 0
                },
                {
                    "sent": "Are pure air less cases and case one has a higher level of foci?",
                    "label": 1
                },
                {
                    "sent": "High frequency of foci in extra motor areas compared to motor neurons.",
                    "label": 0
                },
                {
                    "sent": "As you can see here, where is the other cases of the opposite?",
                    "label": 0
                },
                {
                    "sent": "This is a single case.",
                    "label": 0
                },
                {
                    "sent": "You can't base conclusions on a single case, but the fact that the foci distribution is is is correlating with the clinical phenotype is is interesting and needs further work.",
                    "label": 0
                }
            ]
        },
        "clip_13": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "So the other comparison we did, we looked in whether the foci within motor neurons could predict the presence of TDP pathology.",
                    "label": 0
                },
                {
                    "sent": "You know, I've already said that TDP pathologies you know the Hallmark Pathology Avaya last.",
                    "label": 0
                },
                {
                    "sent": "It's the one pathology that predicts neurodegeneration.",
                    "label": 0
                },
                {
                    "sent": "So when we looked at the sense fosite, we showed that there was no correlation within motor neurons, so the presence of a sense foci within a motor neuron does not predict the presence of TDP, pathology or TP mislocalization.",
                    "label": 0
                },
                {
                    "sent": "And I must admit I came to the antisense expecting to find the same and found the opposite.",
                    "label": 0
                },
                {
                    "sent": "So the presence of an antisense foci within a motor neuron strongly predicts the presence of TDP 43 pathology.",
                    "label": 1
                },
                {
                    "sent": "We came up.",
                    "label": 0
                },
                {
                    "sent": "This result was very interesting, it suggesting a role for the antisense foci, particularly in in your generation, and the review is asked us to go and do more.",
                    "label": 0
                },
                {
                    "sent": "We did more the P value just went down and down.",
                    "label": 0
                },
                {
                    "sent": "You know, I think this is a robust finding.",
                    "label": 0
                }
            ]
        },
        "clip_14": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "So conclude the RNA foci work.",
                    "label": 1
                },
                {
                    "sent": "So the presence of the antisense foci correlates with TDP 43 mislocalization within the motor neurons.",
                    "label": 1
                },
                {
                    "sent": "Now this ends in the antisense foci have similar binding partners, so if that if sequestration of binding proteins is the mechanism of toxicity, they should be equally toxic.",
                    "label": 0
                },
                {
                    "sent": "However, what is different is that different neuronal populations appear to transcribe one or the other preferentially.",
                    "label": 0
                }
            ]
        },
        "clip_15": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And it says it's a more recent papers, sort of.",
                    "label": 0
                },
                {
                    "sent": "I've also highlighted the antisense transcripts, you know, so I think supporting our work and draw particular attention to Laura Adams mouse model Gnosis is seen.",
                    "label": 0
                },
                {
                    "sent": "I'm back mouse model.",
                    "label": 0
                },
                {
                    "sent": "That is, is you know it is it has a robust phenotype.",
                    "label": 0
                },
                {
                    "sent": "It has TDP 43 pathology unlike some of the other C9 back models that they have been sort of published and where I think it really differs from the other mouse models is that it has a higher level of antisense transcription.",
                    "label": 0
                },
                {
                    "sent": "And what's really interesting is that the antisense transcription appears to be highest in the neuronal populations where there is degeneration, whereas this sense transcription and appears to be sort of more uniform across neuronal populations.",
                    "label": 0
                },
                {
                    "sent": "So you know, like our work, sort of highlighting that antisense transcription.",
                    "label": 0
                }
            ]
        },
        "clip_16": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "So quick summary of some gene expression profiling work, so we based on this, you know.",
                    "label": 0
                },
                {
                    "sent": "So there are multiple lines of evidence that have highlighted M RNA splicing in C9.",
                    "label": 0
                },
                {
                    "sent": "So this worker already talked about sort of the foci.",
                    "label": 0
                },
                {
                    "sent": "Perhaps sequestering RNA binding proteins?",
                    "label": 0
                },
                {
                    "sent": "But also, you know, we've the dipeptide repeat proteins thought to disrupt the normal sort of maturation of the splicing proteins.",
                    "label": 0
                },
                {
                    "sent": "So whichever way you come to it, and perhaps both ways at once.",
                    "label": 0
                },
                {
                    "sent": "There's you know you expect a disruption of RNA splicing, and so we tried to sort of measure that.",
                    "label": 0
                },
                {
                    "sent": "So what we did?",
                    "label": 0
                },
                {
                    "sent": "We did some gene expression profiling and we tried to measure splicing errors.",
                    "label": 1
                },
                {
                    "sent": "And how do you define a splicing error?",
                    "label": 0
                },
                {
                    "sent": "So the way we did this is we said that if you take a group of samples, splicing events that are common to all samples are more likely to be not errors.",
                    "label": 0
                },
                {
                    "sent": "But if they if they only occur in one sample, they might not be an error, but they're more likely to be an error.",
                    "label": 0
                },
                {
                    "sent": "So in this way we sort of measured splicing errors, and we showed that.",
                    "label": 0
                },
                {
                    "sent": "Measured in this way, splicing errors are higher in RC9 cases compared to non C9 and to controls, and perhaps most Interestingly cases with a C9 cases with more of these errors have a faster progression than those with less of these errors, and suggesting there's a correlation with clinical phenotype.",
                    "label": 0
                },
                {
                    "sent": "I think that needs further work.",
                    "label": 0
                }
            ]
        },
        "clip_17": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "So where do we go from here?",
                    "label": 0
                },
                {
                    "sent": "So I think you know, I thought about seeing what what might really sort of excited about.",
                    "label": 0
                },
                {
                    "sent": "I think the the forthcoming antisense oligo trial in C9.",
                    "label": 1
                },
                {
                    "sent": "I'm excited about, you know if whether it's the first side of the DPR, if it's gain of function toxicity, I think you know we, that's that's a really exciting trial coming up.",
                    "label": 0
                },
                {
                    "sent": "I think you know I've already highlighted the understands transcription in the role of that, and I think you know we're already seeing good models that sort of highlighting that, and I think the measuring the length of the expansion are Russell talk.",
                    "label": 0
                },
                {
                    "sent": "Yesterday was fantastic and I thought, you know, I think looking to measure the expansion using a nanopore based technology.",
                    "label": 0
                },
                {
                    "sent": "Whether that's Pat BioWare, that's the Oxford nanopore.",
                    "label": 0
                },
                {
                    "sent": "I think that's going to be really important.",
                    "label": 0
                },
                {
                    "sent": "It's kind of the missing piece, you know.",
                    "label": 0
                },
                {
                    "sent": "We've had some hints through studies of anticipation that the repeat length is definitely key.",
                    "label": 0
                },
                {
                    "sent": "But until we can accurately measure the repeat length, we don't know for definite that the repeat length is key and a lot of our our work at the moment is sort of working on that assumption.",
                    "label": 0
                },
                {
                    "sent": "I think it I think it is likely to be, you know, gain of function toxicity that repeat length does determine phenotype, but until we can accurately measure that, it's kind of the missing piece and the other thing I want to highlight, you know, I thought.",
                    "label": 0
                },
                {
                    "sent": "Again, Russell mentioned this the fascinating insight into the genetic architecture of a LS from the project mine work, you know, done so far that.",
                    "label": 1
                },
                {
                    "sent": "We're looking at combinations of rare variants.",
                    "label": 0
                },
                {
                    "sent": "I think that's fascinating.",
                    "label": 0
                },
                {
                    "sent": "I think, as you know, we probably going to discover many, many more genes.",
                    "label": 0
                },
                {
                    "sent": "You know, this whole we've discovered the genes in 80% of familiars samples.",
                    "label": 0
                },
                {
                    "sent": "I think.",
                    "label": 0
                },
                {
                    "sent": "Really, you know, if multiple if patients have several mutations that are all that are rare, acting in combination is going to be so much work to do in dissecting the interactions.",
                    "label": 0
                },
                {
                    "sent": "You know, perhaps seeing synergy synergy between different mutations, and hopefully that's going to highlight lots of therapeutic targets.",
                    "label": 0
                },
                {
                    "sent": "So.",
                    "label": 0
                }
            ]
        },
        "clip_18": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "An I've got so many people to say thank you for for for all of this this work you know it's a lot of a lot of work I've described here.",
                    "label": 0
                },
                {
                    "sent": "I can't mention everybody, I just want to highlight these people so Adrian game, win, pull Robin and my supervisors during my PhD, Janine and Pam.",
                    "label": 0
                },
                {
                    "sent": "This is the US getting wet that spam getting wet outside to trend where we work.",
                    "label": 0
                }
            ]
        },
        "clip_19": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And then just want to highlight collaborators, Vlad, Magnus, John Bryan China Deaton, Michael, born from San Diego and and again I want to highlight the Lymphoblastoid cell bank.",
                    "label": 0
                },
                {
                    "sent": "The MDF used that in a lot of the work I've described to you.",
                    "label": 0
                },
                {
                    "sent": "People who funded me through my PhD, the MDA, the MRC and people from me.",
                    "label": 0
                },
                {
                    "sent": "Now the NHL and thank you for listening.",
                    "label": 0
                }
            ]
        }
    }
}